Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors

Add time:08/29/2019    Source:sciencedirect.com

A series of novel (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives had been synthesized and evaluated their biological activities as potential tubulin polymerization inhibitors. Among these compounds, compound 3q exhibited potent antiproliferative activities against three cancer cell lines in vitro, and antitubulin polymerization activity with IC50 of 0.92 μM, which was superior to that of colchicine (IC50 = 1.34 μM). Docking simulation was performed to insert compound 3q into the crystal structure of tubulin at colchicine binding site to determine the probable binding model. These results suggested that compound 3q may be a promising antitubulin agent for the potential treatment of cancer.

We also recommend Trading Suppliers and Manufacturers of 2-(3,4-dihydroxyphenyl)-2-hydroxy-acetaldehyde (cas 13023-73-9). Pls Click Website Link as below: cas 13023-73-9 suppliers

Prev:Full paper/MémoireNovel mild synthesis of high-added-value p-hydroxyphenyl acetic acid and 3,4-dihydroxyphenyl acetic acid using the acidic clay/hydrogen peroxide catalytic system
Next:Molecular and cellular pharmacologyMethyl (E)-(3-(3,4-dihydroxyphenyl)acryloyl)tryptophanate can suppress MCP-1 expression by inhibiting p38 MAP kinase and NF-κB in LPS-stimulated differentiated THP-1 cells)